| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_56abb7a905b2aba4c53d3d3debee8c14 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-557
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-02 |
| filingDate |
1995-02-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2f05b8e83998147aa3a5f47f694e4caa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cef8e428c8d477d23331552da011e84d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dbccf32c5235e5131cc855a7105cf1b7 |
| publicationDate |
1995-10-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-H07258090-A |
| titleOfInvention |
Circulatory function enhancer |
| abstract |
(57) [Summary] [Purpose] To provide a circulatory function promoting agent having actions such as increase in heart rate, increase in blood pressure, and increase in blood flow. [Structure] The circulation function promoting agent of the present invention is a carboxylic acid type ω 13,14-dihydro-chains substituted with halogen atoms It contains 15-keto-prostaglandin Es or physiologically acceptable salts as an active ingredient. |
| priorityDate |
1995-02-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |